Cargando…

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

Animal models of multiple myeloma vary in terms of consistency of onset, degree of tumour burden and degree of myeloma bone disease. Here we describe five pre-clinical models of myeloma in NOD/SCID-GAMMA mice to specifically study the effects of therapeutic agents on myeloma bone disease. Groups of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawson, Michelle A., Paton-Hough, Julia M., Evans, Holly R., Walker, Rebecca E., Harris, William, Ratnabalan, Dharshi, Snowden, John A., Chantry, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358985/ https://www.ncbi.nlm.nih.gov/pubmed/25768011 http://dx.doi.org/10.1371/journal.pone.0119546

Ejemplares similares

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
por: Paton‐Hough, Julia, et al.
Publicado: (2018)

New agents in the Treatment of Myeloma Bone Disease
por: Ring, Elizabeth S., et al.
Publicado: (2017)

Spiny mice (Acomys) cells fail to engraft in NOD scid gamma
por: Gaire, Janak, et al.
Publicado: (2023)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning
por: Verbiest, Tom, et al.
Publicado: (2016)

Draft Genome Sequences of Klebsiella pneumoniae Strains Isolated from Immunocompromised NOD-scid Gamma Research Mice
por: Mannion, Anthony, et al.
Publicado: (2019)

Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis
por: Unno, Kenji, et al.
Publicado: (2014)

Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice
por: Walcher, Lia, et al.
Publicado: (2018)

Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao, Miao, et al.
Publicado: (2021)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Stewart, Georgia, et al.
Publicado: (2021)

Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis
por: Milsom, Chloe C., et al.
Publicado: (2013)

Reference genomes for BALB/c Nude and NOD/SCID mouse models
por: Schmid-Siegert, Emanuel, et al.
Publicado: (2023)

Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019)

In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice
por: Kosugi, Hiroshi, et al.
Publicado: (2001)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling
por: Queudeville, M, et al.
Publicado: (2012)

Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
por: Hori, Naoko, et al.
Publicado: (2016)

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo
por: Lath, Darren L., et al.
Publicado: (2018)

Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies
por: Schueler, Julia, et al.
Publicado: (2013)

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo
por: Shirasaki, Ryosuke, et al.
Publicado: (2012)

Efficient derivation of embryonic stem cells from NOD-scid Il2rg(−/−) mice
por: Liu, Kang, et al.
Publicado: (2015)

Appearance of Human Plasma Cells Following Differentiation of Human B Cells in NOD/SCID Mouse Spleen
por: Kikuchi, Kentaro, et al.
Publicado: (2003)

Acceleration of Bone Repair in NOD/SCID Mice by Human Monoosteophils, Novel LL-37-Activated Monocytes
por: Zhang, Zhifang, et al.
Publicado: (2013)

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγ(c)(null) Mice
por: Rapp, Anna E., et al.
Publicado: (2016)

Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg(−/−) mice
por: Du, Yaqin, et al.
Publicado: (2018)

Long Term Amperometric Recordings in the Brain Extracellular Fluid of Freely Moving Immunocompromised NOD SCID Mice
por: Reid, Caroline H., et al.
Publicado: (2017)

Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice
por: Was, Halina, et al.
Publicado: (2016)

Spontaneous granulocytic leukemia in a NOD/Shi-scid IL-2Rγ(null) mouse
por: Akane, Hirotoshi, et al.
Publicado: (2021)

Lack of tumorigenesis and protumorigenic activity of human umbilical cord mesenchymal stem cells in NOD SCID mice
por: He, Jie, et al.
Publicado: (2022)

Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation
por: Nowlan, Bianca, et al.
Publicado: (2021)

Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo
por: Vitovski, Srdjan, et al.
Publicado: (2012)

Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice
por: LIU, XIANG, et al.
Publicado: (2014)

Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia–reperfusion
por: van Zuylen, Vanessa-Leigh, et al.
Publicado: (2015)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016)

Dynamic Tracking Human Mesenchymal Stem Cells Tropism following Smoke Inhalation Injury in NOD/SCID Mice
por: Song, MeiJuan, et al.
Publicado: (2016)

Correction to: Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg(−/−) mice
por: Du, Yaqin, et al.
Publicado: (2018)

Deciphering reproductive aging in women using a NOD/SCID mouse model for distinct physiological ovarian phenotypes
por: Marchante, María, et al.
Publicado: (2023)

Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
por: Flavell, D J, et al.
Publicado: (2000)

A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
por: Calimeri, T, et al.
Publicado: (2011)

Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate
por: CIFUENTES, FEDERICO F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gruop9sbaq1j37vnnr8euao0es